RNA-Binding Proteins: A Role in Neurotoxicity?

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Neurodegenerative diseases remain a leading cause of death, with limited molecular understanding hindering novel therapeutic development.
• Neurons rely on precise control of gene expression, particularly at the post-transcriptional level, to maintain protein homeostasis.
• RNA-binding proteins (RBPs) regulate gene expression through ribonucleoprotein complexes, influencing processes from splicing to translation.

Purpose of the Study:

• To summarize recent findings on the molecular mechanisms of RBPs in RNA processing related to neurodegenerative diseases.
• To explore the role of RBPs in neurotoxicity and their connection to specific neurodegenerative conditions.
• To highlight RBPs as potential therapeutic targets for neurodegenerative pathologies.

Main Methods:

• Review of recent literature on RNA-binding proteins and neurodegenerative diseases.
• Analysis of molecular mechanisms underlying RBP function in neurons and glial cells.
• Discussion of the link between RBP dysregulation and neurotoxic events.

Main Results:

• Disruption of RBP levels or function in neural cells triggers neurotoxicity.
• RBPs are implicated in the pathogenesis of diseases like spinal muscular atrophy, ALS, fragile X syndrome, and FTD.
• RBPs critically regulate post-transcriptional processes essential for neuronal health.

Conclusions:

• The intricate role of RBPs in RNA processing is central to understanding neurodegeneration.
• Targeting RBPs offers a promising new avenue for developing interventions for neurodegenerative diseases.
• Further research into RBP mechanisms can unlock novel therapeutic strategies.